TreeWAS – Variant ID: rs73389468

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter VII Diseases of the eye and adnexa	1.000	0.000
Chapter II Neoplasms	0.999	0.001
Chapter X Diseases of the respiratory system	0.997	0.003
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.996	0.004
Chapter IX Diseases of the circulatory system	0.995	0.005
Chapter XV Pregnancy, childbirth and the puerperium	0.994	0.006
Chapter XX External causes of morbidity and mortality	0.993	0.007
H30-H36 Disorders of choroid and retina	0.990	0.010
J90-J94 Other diseases of pleura	0.989	0.011
Chapter VIII Diseases of the ear and mastoid process	0.985	0.015
Chapter IV Endocrine, nutritional and metabolic diseases	0.981	0.019
C15-C26 Malignant neoplasms of digestive organs	0.979	0.021
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.975	0.025
Chapter I Certain infectious and parasitic diseases	0.967	0.033
H53-H54 Visual disturbances and blindness	0.959	0.041
C64-C68 Malignant neoplasms of urinary tract	0.958	0.042
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.954	0.046
H25-H28 Disorders of lens	0.954	0.046
E10-E14 Diabetes mellitus	0.949	0.051
J90 Pleural effusion, not elsewhere classified	0.947	0.053
H90-H95 Other disorders of ear	0.943	0.057
C15 Malignant neoplasm of oesophagus	0.940	0.060
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.940	0.060
H26 Other cataract	0.935	0.065
I60-I69 Cerebrovascular diseases	0.934	0.066
J93 Pneumothorax	0.931	0.069
H35 Other retinal disorders	0.929	0.071
J20-J22 Other acute lower respiratory infections	0.928	0.072
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.924	0.076
H26.9 Cataract, unspecified	0.924	0.076
Chapter VI Diseases of the nervous system	0.923	0.077
E10 Insulin-dependent diabetes mellitus	0.920	0.080
C79 Secondary malignant neoplasm of other sites	0.919	0.081
C67 Malignant neoplasm of bladder	0.916	0.084
O60-O75 Complications of labour and delivery	0.916	0.084
M45-M49 Spondylopathies	0.914	0.086
I10-I15 Hypertensive diseases	0.908	0.092
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.905	0.095
H53 Visual disturbances	0.905	0.095
A30-A49 Other bacterial diseases	0.902	0.098
I20-I25 Ischaemic heart diseases	0.897	0.103
Chapter XI Diseases of the digestive system	0.896	0.104
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.892	0.108
M15-M19 Arthrosis	0.891	0.109
M05-M14 Inflammatory polyarthropathies	0.890	0.110
I12 Hypertensive renal disease	0.889	0.111
D00-D09 In situ neoplasms	0.887	0.112
J93.9 Pneumothorax, unspecified	0.886	0.114
O20-O29 Other maternal disorders predominantly related to pregnancy	0.885	0.115
H33 Retinal detachments and breaks	0.882	0.118
G50-G59 Nerve, nerve root and plexus disorders	0.879	0.121
K65-K67 Diseases of peritoneum	0.876	0.124
I12.0 Hypertensive renal disease with renal failure	0.874	0.126
H65-H75 Diseases of middle ear and mastoid	0.873	0.127
O42 Premature rupture of membranes	0.873	0.127
K02 Dental caries	0.873	0.127
H90 Conductive and sensorineural hearing loss	0.871	0.129
I63 Cerebral infarction	0.867	0.133
K02.9 Dental caries, unspecified	0.859	0.141
E20-E35 Disorders of other endocrine glands	0.859	0.141
M70-M79 Other soft tissue disorders	0.859	0.141
E10.9 Without complications	0.858	0.142
J22 Unspecified acute lower respiratory infection	0.858	0.142
O63 Long labour	0.856	0.144
K66 Other disorders of peritoneum	0.856	0.144
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.854	0.146
I05-I09 Chronic rheumatic heart diseases	0.852	0.148
H43-H45 Disorders of vitreous body and globe	0.850	0.150
Y86 Sequelae of other accidents	0.847	0.153
H60-H62 Diseases of external ear	0.846	0.154
M17 Gonarthrosis [arthrosis of knee]	0.844	0.156
C25 Malignant neoplasm of pancreas	0.844	0.156
O20 Haemorrhage in early pregnancy	0.843	0.157
I60 Subarachnoid haemorrhage	0.842	0.158
K66.0 Peritoneal adhesions	0.841	0.159
H92 Otalgia and effusion of ear	0.841	0.159
H36 Retinal disorders in diseases classified elsewhere	0.840	0.160
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.840	0.160
H34 Retinal vascular occlusions	0.839	0.160
A41 Other septicaemia	0.834	0.166
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.834	0.166
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.833	0.167
M17.1 Other primary gonarthrosis	0.830	0.170
J40-J47 Chronic lower respiratory diseases	0.830	0.170
C15.9 Oesophagus, unspecified	0.829	0.171
H55-H59 Other disorders of eye and adnexa	0.828	0.172
H53.2 Diplopia	0.825	0.175
M80-M85 Disorders of bone density and structure	0.824	0.176
M06 Other rheumatoid arthritis	0.822	0.178
C16 Malignant neoplasm of stomach	0.821	0.179
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.821	0.179
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.818	0.182
E10.3 With ophthalmic complications	0.817	0.183
I63.9 Cerebral infarction, unspecified	0.815	0.185
H35.0 Background retinopathy and retinal vascular changes	0.815	0.185
Chapter XXII Codes for special purposes	0.813	0.187
H54 Blindness and low vision	0.812	0.188
Chapter XII Diseases of the skin and subcutaneous tissue	0.811	0.189
J91 Pleural effusion in conditions classified elsewhere	0.808	0.191
K08 Other disorders of teeth and supporting structures	0.805	0.195
M79 Other soft tissue disorders, not elsewhere classified	0.799	0.201
C20 Malignant neoplasm of rectum	0.796	0.204
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.796	0.204
J47 Bronchiectasis	0.795	0.205
Y43 Primarily systemic agents	0.793	0.207
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.792	0.208
M47 Spondylosis	0.791	0.209
I20 Angina pectoris	0.791	0.209
C15.3 Upper third of oesophagus	0.790	0.210
C67.2 Lateral wall of bladder	0.788	0.212
M20-M25 Other joint disorders	0.787	0.213
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.786	0.214
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.785	0.215
O00-O08 Pregnancy with abortive outcome	0.785	0.215
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.784	0.216
B35-B49 Mycoses	0.784	0.216
M91-M94 Chondropathies	0.784	0.216
O94-O99 Other obstetric conditions, not elsewhere classified	0.782	0.218
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.781	0.219
H35.8 Other specified retinal disorders	0.779	0.221
C67.9 Bladder, unspecified	0.779	0.221
C15.4 Middle third of oesophagus	0.778	0.222
O20.9 Haemorrhage in early pregnancy, unspecified	0.778	0.222
O35 Maternal care for known or suspected foetal abnormality and damage	0.778	0.222
O63.1 Prolonged second stage (of labour)	0.777	0.223
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.774	0.226
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.774	0.226
H53.4 Visual field defects	0.773	0.227
Y44 Agents primarily affecting blood constituents	0.772	0.227
H33.2 Serous retinal detachment	0.772	0.228
M46 Other inflammatory spondylopathies	0.772	0.228
I70-I79 Diseases of arteries, arterioles and capillaries	0.772	0.228
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.771	0.228
Y57 Other and unspecified drugs and medicaments	0.770	0.230
C64 Malignant neoplasm of kidney, except renal pelvis	0.769	0.231
H10-H13 Disorders of conjunctiva	0.769	0.231
H27 Other disorders of lens	0.767	0.233
G80-G83 Cerebral palsy and other paralytic syndromes	0.765	0.235
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.762	0.238
H93 Other disorders of ear, not elsewhere classified	0.760	0.240
O75 Other complications of labour and delivery, not elsewhere classified	0.760	0.240
M40-M43 Deforming dorsopathies	0.759	0.241
Y42.7 Androgens and anabolic congeners	0.758	0.242
Y85 Sequelae of transport accidents	0.757	0.243
A50-A64 Infections with a predominantly sexual mode of transmission	0.757	0.243
J80-J84 Other respiratory diseases principally affecting the interstitium	0.757	0.243
L40-L45 Papulosquamous disorders	0.756	0.244
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.755	0.245
O46 Antepartum haemorrhage, not elsewhere classified	0.754	0.246
A41.5 Septicaemia due to other Gram-negative organisms	0.753	0.247
H92.1 Otorrhoea	0.751	0.249
H90.2 Conductive hearing loss, unspecified	0.751	0.249
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.751	0.249
M00-M03 Infectious arthropathies	0.751	0.249
C67.5 Bladder neck	0.750	0.250
A00-A09 Intestinal infectious diseases	0.750	0.250
B25-B34 Other viral diseases	0.747	0.253
C15.5 Lower third of oesophagus	0.746	0.254
J30-J39 Other diseases of upper respiratory tract	0.744	0.256
J20 Acute bronchitis	0.743	0.257
C51-C58 Malignant neoplasms of female genital organs	0.742	0.257
H90.3 Sensorineural hearing loss, bilateral	0.742	0.258
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.741	0.259
I89.0 Lymphoedema, not elsewhere classified	0.740	0.260
L00-L08 Infections of the skin and subcutaneous tissue	0.740	0.260
Y41 Other systemic anti-infectives and antiparasitics	0.739	0.261
H60 Otitis externa	0.739	0.261
K14 Diseases of tongue	0.737	0.263
M86-M90 Other osteopathies	0.737	0.263
V80-V89 Other land transport accidents	0.737	0.263
H35.4 Peripheral retinal degeneration	0.736	0.264
M06.9 Rheumatoid arthritis, unspecified	0.735	0.265
C25.0 Head of pancreas	0.735	0.265
C80 Malignant neoplasm without specification of site	0.735	0.265
D04 Carcinoma in situ of skin	0.734	0.266
H36.0 Diabetic retinopathy	0.733	0.267
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.732	0.268
Y42.0 Glucocorticoids and synthetic analogs	0.732	0.268
O20.0 Threatened abortion	0.732	0.268
K08.3 Retained dental root	0.732	0.268
H34.8 Other retinal vascular occlusions	0.732	0.268
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.731	0.269
B15-B19 Viral hepatitis	0.729	0.271
J95-J99 Other diseases of the respiratory system	0.728	0.271
H53.9 Visual disturbance, unspecified	0.728	0.272
M48 Other spondylopathies	0.727	0.273
J60-J70 Lung diseases due to external agents	0.726	0.273
A49 Bacterial infection of unspecified site	0.725	0.275
Y52 Agents primarily affecting the cardiovascular system	0.725	0.275
E14 Unspecified diabetes mellitus	0.725	0.275
C67.6 Ureteric orifice	0.724	0.276
O47 False labour	0.723	0.277
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.721	0.279
C79.2 Secondary malignant neoplasm of skin	0.721	0.279
E10.4 With neurological complications	0.720	0.280
C19 Malignant neoplasm of rectosigmoid junction	0.720	0.280
M47.9 Spondylosis, unspecified	0.720	0.280
C79.6 Secondary malignant neoplasm of ovary	0.718	0.282
H72 Perforation of tympanic membrane	0.718	0.282
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
H46-H48 Disorders of optic nerve and visual pathways	0.717	0.283
I22 Subsequent myocardial infarction	0.717	0.283
K04 Diseases of pulp and periapical tissues	0.717	0.283
C83 Diffuse non-Hodgkin's lymphoma	0.716	0.284
E70-E90 Metabolic disorders	0.716	0.284
C40-C41 Malignant neoplasms of bone and articular cartilage	0.716	0.284
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.716	0.284
I64 Stroke, not specified as haemorrhage or infarction	0.715	0.285
M60-M63 Disorders of muscles	0.714	0.285
I00-I02 Acute rheumatic fever	0.714	0.286
I20.0 Unstable angina	0.714	0.286
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.713	0.287
O42.9 Premature rupture of membranes, unspecified	0.713	0.287
O85-O92 Complications predominantly related to the puerperium	0.713	0.287
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.712	0.288
G50 Disorders of trigeminal nerve	0.712	0.288
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.712	0.288
Y35-Y36 Legal intervention and operations of war	0.712	0.288
Y10-Y34 Event of undetermined intent	0.712	0.288
Y00-Y09 Assault	0.712	0.288
X85-X99 Assault	0.712	0.288
X58-X59 Accidental exposure to other and unspecified factors	0.712	0.288
X50-X57 Overexertion, travel and privation	0.712	0.288
X40-X49 Accidental poisoning by and exposure to noxious substances	0.712	0.288
X30-X39 Exposure to forces of nature	0.712	0.288
X20-X29 Contact with venomous animals and plants	0.712	0.288
X10-X19 Contact with heat and hot substances	0.712	0.288
X00-X09 Exposure to smoke, fire and flames	0.712	0.288
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.712	0.288
W75-W84 Other accidental threats to breathing	0.712	0.288
W65-W74 Accidental drowning and submersion	0.712	0.288
W50-W64 Exposure to animate mechanical forces	0.712	0.288
V98-V99 Other and unspecified transport accidents	0.712	0.288
V95-V97 Air and space transport accidents	0.712	0.288
V90-V94 Water transport accidents	0.712	0.288
V70-V79 Bus occupant injured in transport accident	0.712	0.288
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.712	0.288
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.712	0.288
V40-V49 Car occupant injured in transport accident	0.712	0.288
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.712	0.288
V20-V29 Motorcycle rider injured in transport accident	0.712	0.288
V01-V09 Pedestrian injured in transport accident	0.712	0.288
O34 Maternal care for known or suspected abnormality of pelvic organs	0.711	0.289
H74 Other disorders of middle ear and mastoid	0.711	0.289
K11 Diseases of salivary glands	0.711	0.289
G56 Mononeuropathies of upper limb	0.711	0.289
X60-X84 Intentional self-harm	0.710	0.290
H32 Chorioretinal disorders in diseases classified elsewhere	0.710	0.290
H31 Other disorders of choroid	0.710	0.290
H30 Chorioretinal inflammation	0.710	0.290
H26.4 After-cataract	0.709	0.291
J94 Other pleural conditions	0.709	0.291
Y42.5 Other oestrogens and progestogens	0.707	0.293
W20-W49 Exposure to inanimate mechanical forces	0.707	0.293
G53 Cranial nerve disorders in diseases classified elsewhere	0.705	0.295
L40 Psoriasis	0.704	0.296
E40-E46 Malnutrition	0.703	0.296
G51 Facial nerve disorders	0.703	0.297
O64 Obstructed labour due to malposition and malpresentation of foetus	0.703	0.297
O41 Other disorders of amniotic fluid and membranes	0.703	0.297
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.703	0.297
Chapter XIV Diseases of the genitourinary system	0.702	0.298
C26 Malignant neoplasm of other and ill-defined digestive organs	0.702	0.298
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.702	0.298
C21 Malignant neoplasm of anus and anal canal	0.702	0.298
C17 Malignant neoplasm of small intestine	0.702	0.298
C23 Malignant neoplasm of gallbladder	0.702	0.298
G54 Nerve root and plexus disorders	0.702	0.298
E50-E64 Other nutritional deficiencies	0.701	0.298
H44 Disorders of globe	0.701	0.299
I24 Other acute ischaemic heart diseases	0.700	0.300
D37-D48 Neoplasms of uncertain or unknown behaviour	0.700	0.300
C79.9 Secondary malignant neoplasm, unspecified site	0.699	0.301
Y59 Other and unspecified vaccines and biological substances	0.699	0.301
Y58 Bacterial vaccines	0.699	0.301
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.699	0.301
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.699	0.301
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.699	0.301
Y53 Agents primarily affecting the gastro-intestinal system	0.699	0.301
Y50 Central nervous system stimulants, not elsewhere classified	0.699	0.301
Y49 Psychotropic drugs, not elsewhere classified	0.699	0.301
Y48 Anaesthetics and therapeutic gases	0.699	0.301
Y47 Sedatives, hypnotics and antianxiety drugs	0.699	0.301
Y46 Antiepileptics and anti-Parkinsonism drugs	0.699	0.301
M79.6 Pain in limb	0.699	0.301
Y45.1 Salicylates	0.699	0.301
H40-H42 Glaucoma	0.698	0.302
D06 Carcinoma in situ of cervix uteri	0.697	0.303
K65 Peritonitis	0.696	0.304
M18 Arthrosis of first carpometacarpal joint	0.696	0.304
I08 Multiple valve diseases	0.696	0.304
E13 Other specified diabetes mellitus	0.696	0.304
M79.8 Other specified soft tissue disorders	0.696	0.304
H54.7 Unspecified visual loss	0.696	0.304
B99-B99 Other infectious diseases	0.694	0.306
B90-B94 Sequelae of infectious and parasitic diseases	0.694	0.306
B85-B89 Pediculosis, acariasis and other infestations	0.694	0.306
B65-B83 Helminthiases	0.694	0.306
B50-B64 Protozoal diseases	0.694	0.306
B20-B24 Human immunodeficiency virus [HIV] disease	0.694	0.306
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.694	0.306
A80-A89 Viral infections of the central nervous system	0.694	0.306
A75-A79 Rickettsioses	0.694	0.306
A70-A74 Other diseases caused by chlamydiae	0.694	0.306
A65-A69 Other spirochaetal diseases	0.694	0.306
A20-A28 Certain zoonotic bacterial diseases	0.694	0.306
A15-A19 Tuberculosis	0.694	0.306
D07 Carcinoma in situ of other and unspecified genital organs	0.693	0.307
O80-O84 Delivery	0.693	0.307
E65-E68 Obesity and other hyperalimentation	0.693	0.307
M80 Osteoporosis with pathological fracture	0.692	0.308
J93.1 Other spontaneous pneumothorax	0.692	0.308
C90 Multiple myeloma and malignant plasma cell neoplasms	0.692	0.308
M06.0 Seronegative rheumatoid arthritis	0.692	0.308
O66 Other obstructed labour	0.691	0.309
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.690	0.310
M72 Fibroblastic disorders	0.690	0.310
V10-V19 Pedal cyclist injured in transport accident	0.689	0.311
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.688	0.312
M24 Other specific joint derangements	0.687	0.313
Y45.0 Opioids and related analgesics	0.687	0.313
C68 Malignant neoplasm of other and unspecified urinary organs	0.687	0.313
C66 Malignant neoplasm of ureter	0.687	0.313
C65 Malignant neoplasm of renal pelvis	0.687	0.313
G57 Mononeuropathies of lower limb	0.686	0.313
J46 Status asthmaticus	0.686	0.314
J92 Pleural plaque	0.686	0.314
N10-N16 Renal tubulo-interstitial diseases	0.686	0.314
I07 Rheumatic tricuspid valve diseases	0.686	0.314
E00-E07 Disorders of thyroid gland	0.686	0.314
H65 Nonsuppurative otitis media	0.685	0.315
E11 Non-insulin-dependent diabetes mellitus	0.685	0.315
C76 Malignant neoplasm of other and ill-defined sites	0.684	0.316
O63.9 Long labour, unspecified	0.684	0.316
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.684	0.316
H35.3 Degeneration of macula and posterior pole	0.684	0.316
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.684	0.316
I87 Other disorders of veins	0.683	0.317
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.683	0.317
A41.2 Septicaemia due to unspecified staphylococcus	0.682	0.317
H33.0 Retinal detachment with retinal break	0.682	0.318
Y40 Systemic antibiotics	0.682	0.318
G90-G99 Other disorders of the nervous system	0.681	0.319
Y60-Y69 Misadventures to patients during surgical and medical care	0.681	0.319
E12 Malnutrition-related diabetes mellitus	0.681	0.319
L03 Cellulitis	0.680	0.320
I60.9 Subarachnoid haemorrhage, unspecified	0.680	0.320
I20.1 Angina pectoris with documented spasm	0.678	0.322
E87 Other disorders of fluid, electrolyte and acid-base balance	0.678	0.322
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.676	0.324
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.676	0.324
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.676	0.324
H94 Other disorders of ear in diseases classified elsewhere	0.676	0.324
H43 Disorders of vitreous body	0.676	0.324
N13 Obstructive and reflux uropathy	0.676	0.324
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.675	0.324
D09 Carcinoma in situ of other and unspecified sites	0.675	0.325
C15.8 Overlapping lesion of oesophagus	0.674	0.326
C15.2 Abdominal part of oesophagus	0.674	0.326
C15.1 Thoracic part of oesophagus	0.674	0.326
C15.0 Cervical part of oesophagus	0.674	0.326
C67.4 Posterior wall of bladder	0.674	0.326
E24 Cushing's syndrome	0.674	0.326
O45 Premature separation of placenta [abruptio placentae]	0.674	0.326
O44 Placenta praevia	0.674	0.326
O43 Placental disorders	0.674	0.326
O33 Maternal care for known or suspected disproportion	0.674	0.326
O31 Complications specific to multiple gestation	0.674	0.326
O30 Multiple gestation	0.674	0.326
O40 Polyhydramnios	0.674	0.326
E28 Ovarian dysfunction	0.673	0.327
G56.2 Lesion of ulnar nerve	0.672	0.328
H90.5 Sensorineural hearing loss, unspecified	0.672	0.328
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.672	0.328
L40.9 Psoriasis, unspecified	0.672	0.328
I89.1 Lymphangitis	0.671	0.329
A04 Other bacterial intestinal infections	0.671	0.329
H26.3 Drug-induced cataract	0.671	0.329
H26.2 Complicated cataract	0.671	0.329
H26.1 Traumatic cataract	0.671	0.329
H26.0 Infantile, juvenile and presenile cataract	0.671	0.329
M07 Psoriatic and enteropathic arthropathies	0.670	0.330
I68 Cerebrovascular disorders in diseases classified elsewhere	0.670	0.330
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.670	0.330
O63.0 Prolonged first stage (of labour)	0.669	0.331
J93.8 Other pneumothorax	0.668	0.332
J93.0 Spontaneous tension pneumothorax	0.668	0.332
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.667	0.333
K06 Other disorders of gingiva and edentulous alveolar ridge	0.667	0.333
D03 Melanoma in situ	0.666	0.334
H35.9 Retinal disorder, unspecified	0.666	0.334
H35.7 Separation of retinal layers	0.666	0.334
H35.6 Retinal haemorrhage	0.666	0.334
H35.5 Hereditary retinal dystrophy	0.666	0.334
H35.2 Other proliferative retinopathy	0.666	0.334
H35.1 Retinopathy of prematurity	0.666	0.334
J21 Acute bronchiolitis	0.665	0.334
M05 Seropositive rheumatoid arthritis	0.664	0.336
O73 Retained placenta and membranes, without haemorrhage	0.664	0.336
O04 Medical abortion	0.664	0.336
Y43.3 Other antineoplastic drugs	0.663	0.337
Y89 Sequelae of other external causes	0.662	0.337
Y88 Sequelae of surgical and medical care as external cause	0.662	0.337
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.662	0.337
M11 Other crystal arthropathies	0.662	0.338
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.662	0.338
G70-G73 Diseases of myoneural junction and muscle	0.662	0.338
G00-G09 Inflammatory diseases of the central nervous system	0.662	0.338
I61 Intracerebral haemorrhage	0.662	0.338
K70-K77 Diseases of liver	0.662	0.338
C16.9 Stomach, unspecified	0.661	0.338
E22 Hyperfunction of pituitary gland	0.660	0.340
M76 Enthesopathies of lower limb, excluding foot	0.660	0.340
I12.9 Hypertensive renal disease without renal failure	0.660	0.340
E10.8 With unspecified complications	0.660	0.340
E10.7 With multiple complications	0.660	0.340
E10.6 With other specified complications	0.660	0.340
E10.5 With peripheral circulatory complications	0.660	0.340
E10.2 With renal complications	0.660	0.340
E10.0 With coma	0.660	0.340
H33.3 Retinal breaks without detachment	0.660	0.340
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.659	0.341
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.659	0.341
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.659	0.341
O69 Labour and delivery complicated by umbilical cord complications	0.657	0.342
C79.7 Secondary malignant neoplasm of adrenal gland	0.657	0.343
N20-N23 Urolithiasis	0.657	0.343
C67.8 Overlapping lesion of bladder	0.657	0.343
C67.7 Urachus	0.657	0.343
C67.3 Anterior wall of bladder	0.657	0.343
C67.1 Dome of bladder	0.657	0.343
C67.0 Trigone of bladder	0.657	0.343
O74 Complications of anaesthesia during labour and delivery	0.657	0.343
O71 Other obstetric trauma	0.657	0.343
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.657	0.343
O65 Obstructed labour due to maternal pelvic abnormality	0.657	0.343
O62 Abnormalities of forces of labour	0.657	0.343
O61 Failed induction of labour	0.657	0.343
O60 Preterm delivery	0.657	0.343
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.657	0.343
G30-G32 Other degenerative diseases of the nervous system	0.656	0.344
C16.0 Cardia	0.656	0.344
M49 Spondylopathies in diseases classified elsewhere	0.656	0.344
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.655	0.344
Y95 Nosocomial condition	0.655	0.345
I73 Other peripheral vascular diseases	0.654	0.346
M79.66 Pain in limb (Lower leg)	0.652	0.348
I15 Secondary hypertension	0.651	0.349
I13 Hypertensive heart and renal disease	0.651	0.349
I11 Hypertensive heart disease	0.651	0.349
S70-S79 Injuries to the hip and thigh	0.651	0.349
G59 Mononeuropathy in diseases classified elsewhere	0.651	0.349
H55 Nystagmus and other irregular eye movements	0.651	0.349
J33 Nasal polyp	0.651	0.349
Y42.9 Other and unspecified hormone antagonists	0.649	0.351
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.649	0.351
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.649	0.351
Y42.4 Oral contraceptives	0.649	0.351
Y42.2 Antithyroid drugs	0.649	0.351
Y42.1 Thyroid hormones and substitutes	0.649	0.351
H53.6 Night blindness	0.649	0.351
H53.5 Colour vision deficiencies	0.649	0.351
H53.3 Other disorders of binocular vision	0.649	0.351
H80-H83 Diseases of inner ear	0.648	0.352
M46.4 Discitis, unspecified	0.647	0.353
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.647	0.353
H53.1 Subjective visual disturbances	0.647	0.353
A48 Other bacterial diseases, not elsewhere classified	0.647	0.353
A44 Bartonellosis	0.647	0.353
A43 Nocardiosis	0.647	0.353
A42 Actinomycosis	0.647	0.353
A40 Streptococcal septicaemia	0.647	0.353
A39 Meningococcal infection	0.647	0.353
A37 Whooping cough	0.647	0.353
A36 Diphtheria	0.647	0.353
A32 Listeriosis	0.647	0.353
A31 Infection due to other mycobacteria	0.647	0.353
A30 Leprosy [Hansen's disease]	0.647	0.353
A46 Erysipelas	0.647	0.353
A38 Scarlet fever	0.647	0.353
A35 Other tetanus	0.647	0.353
A34 Obstetrical tetanus	0.647	0.353
A33 Tetanus neonatorum	0.647	0.353
M19 Other arthrosis	0.646	0.354
H66 Suppurative and unspecified otitis media	0.646	0.354
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.645	0.355
H92.0 Otalgia	0.645	0.355
K09 Cysts of oral region, not elsewhere classified	0.645	0.355
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.644	0.356
I23 Certain current complications following acute myocardial infarction	0.643	0.357
I85 Oesophageal varices	0.642	0.358
K10 Other diseases of jaws	0.639	0.361
K07 Dentofacial anomalies [including malocclusion]	0.639	0.361
K03 Other diseases of hard tissues of teeth	0.639	0.361
K00 Disorders of tooth development and eruption	0.639	0.361
M15 Polyarthrosis	0.639	0.361
M14 Arthropathies in other diseases classified elsewhere	0.638	0.362
M12 Other specific arthropathies	0.638	0.362
M09 Juvenile arthritis in diseases classified elsewhere	0.638	0.362

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations